BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 33951898)

  • 21. En bloc perfluorodissection for tractional retinal detachment in proliferative diabetic retinopathy.
    Arevalo JF
    Ophthalmology; 2008 Jun; 115(6):e21-5. PubMed ID: 18423870
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surgical and visual outcome following 20-gauge vitrectomy in proliferative diabetic retinopathy over a 10-year period, evidence for change in practice.
    Gupta B; Wong R; Sivaprasad S; Williamson TH
    Eye (Lond); 2012 Apr; 26(4):576-82. PubMed ID: 22241020
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CLINICAL CHARACTERISTICS OF EALES DISEASE AND THE EFFICACY OF DIFFERENT INTERVENTIONS FOR NEOVASCULAR COMPLICATIONS.
    Zhao XY; Cheng SY; Zhang WF; Meng LH; Chen YX
    Retina; 2022 Oct; 42(10):1975-1988. PubMed ID: 36129269
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Macular changes after primary retinectomy for retinal detachment complicated by proliferative vitreoretinopathy.
    Grassi P; Charteris D
    Clin Exp Optom; 2024 May; 107(4):434-441. PubMed ID: 37674262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined 23-gauge sutureless vitrectomy and clear corneal phacoemulsification in patients with proliferative diabetic retinopathy.
    Lee DY; Jeong HS; Sohn HJ; Nam DH
    Retina; 2011 Oct; 31(9):1753-8. PubMed ID: 21555968
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of 23-gauge and 20-gauge vitrectomy for proliferative sickle cell retinopathy - clinical outcomes and surgical management.
    Ho J; Grabowska A; Ugarte M; Muqit MM
    Eye (Lond); 2018 Sep; 32(9):1449-1454. PubMed ID: 29786087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of intravitreal bevacizumab in Eales disease with dense vitreous hemorrhage: a prospective randomized control study.
    Patwardhan SD; Azad R; Shah BM; Sharma Y
    Retina; 2011 May; 31(5):866-70. PubMed ID: 21301382
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative evaluation of early vs. deferred vitrectomy in Eales' disease.
    Kumar A; Tiwari HK; Singh RP; Verma L; Prasad N
    Acta Ophthalmol Scand; 2000 Feb; 78(1):77-8. PubMed ID: 10726795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Timing of vitrectomy for proliferative diabetic retinopathy in cases with type II diabetes mellitus].
    Li X; Jiang Y; Ye C; Li C
    Zhonghua Yan Ke Za Zhi; 1999 Mar; 35(2):116-8. PubMed ID: 11835788
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of Tamponade in Vitrectomy for Proliferative Diabetic Retinopathy with Vitreous Hemorrhage.
    Balakrishnan D; Jain B; Nayaka A; Rani PK; Mukundaprasad V; Jalali S
    Semin Ophthalmol; 2017; 32(4):488-491. PubMed ID: 27128601
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anatomy and function of the macula in patients after retinectomy for retinal detachment complicated by proliferative vitreoretinopathy.
    Stopa M; Kociecki J
    Eur J Ophthalmol; 2011; 21(4):468-72. PubMed ID: 21140368
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peeling of internal limiting membrane during vitrectomy for complicated retinal detachment prevents epimacular membrane formation.
    Aras C; Arici C; Akar S; Müftüoglu G; Yolar M; Arvas S; Baserer T; Koyluoglu N
    Graefes Arch Clin Exp Ophthalmol; 2009 May; 247(5):619-23. PubMed ID: 19107502
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early postoperative retinal thickness changes and complications after vitrectomy for diabetic macular edema.
    Yamamoto T; Hitani K; Tsukahara I; Yamamoto S; Kawasaki R; Yamashita H; Takeuchi S
    Am J Ophthalmol; 2003 Jan; 135(1):14-9. PubMed ID: 12504691
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcomes and complications of 25-gauge transconjunctival sutureless vitrectomy for proliferative diabetic retinopathy.
    Ozone D; Hirano Y; Ueda J; Yasukawa T; Yoshida M; Ogura Y
    Ophthalmologica; 2011; 226(2):76-80. PubMed ID: 21613797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vitreoretinal surgery for complications of choroidal tumor biopsy.
    Grixti A; Angi M; Damato BE; Jmor F; Konstantinidis L; Groenewald C; Heimann H
    Ophthalmology; 2014 Dec; 121(12):2482-8. PubMed ID: 25085629
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term outcomes of sutureless 25-G+ pars-plana vitrectomy for the management of diabetic tractional retinal detachment.
    Mikhail M; Ali-Ridha A; Chorfi S; Kapusta MA
    Graefes Arch Clin Exp Ophthalmol; 2017 Feb; 255(2):255-261. PubMed ID: 27480177
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Retrospective comparison of 25-gauge vitrectomy with 20-gauge vitrectomy in the repair of retinal detachment complicated with proliferative vitreoretinopathy].
    Sato T; Emi K; Bando H; Ikeda T
    Nippon Ganka Gakkai Zasshi; 2012 Feb; 116(2):100-7. PubMed ID: 22509698
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vitrectomy for rhegmatogenous or tractional retinal detachment with familial exudative vitreoretinopathy.
    Ikeda T; Fujikado T; Tano Y; Tsujikawa K; Koizumi K; Sawa H; Yasuhara T; Maeda K; Kinoshita S
    Ophthalmology; 1999 Jun; 106(6):1081-5. PubMed ID: 10366074
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tractional retinal detachment after branch retinal vein occlusion. Influence of disc neovascularization on the outcome of vitreous surgery.
    Ikuno Y; Ikeda T; Sato Y; Tano Y
    Ophthalmology; 1998 Mar; 105(3):417-23. PubMed ID: 9499770
    [TBL] [Abstract][Full Text] [Related]  

  • 40. VITRECTOMY FOR VITREOUS HEMORRHAGE ASSOCIATED WITH RETINAL VEIN OCCLUSION: Visual Outcomes, Prognostic Factors, and Sequelae.
    Wakabayashi T; Patel N; Bough M; Nahar A; Sheng Y; Momenaei B; Salabati M; Mahmoudzadeh R; Kuriyan AE; Spirn MJ; Chiang A; Hsu J; Fineman MS; Regillo CD; Sivalingam A; Ho AC; Gupta OP; Yonekawa Y
    Retina; 2023 Sep; 43(9):1506-1513. PubMed ID: 37294906
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.